Immunotherapies Attack Cancers and Grow Portfolios: Mara Goldstein

By International Business Times July 26, 2012, 03:07:02 PM EDT

Immunotherapies Attack Cancers and Grow Portfolios: Mara Goldstein

Source: George S. Mack of The Life Sciences Report   (7/26/12)

http://www.thelifesciencesreport.com/pub/na/13956

Sometimes valuations don't match the fundamentals of a stock, according to Cantor Fitzgerald & Co. Senior Biotechnology Analyst Mara Goldstein, who understands the science and its relationship to value. Goldstein recommends a handful of small-cap immunotherapy companies that were up 14-42% over the month of June; she also has one large-cap idea for more patient investors. In this exclusive interview with The Life Sciences Report , Goldstein makes a case for favorite companies that should continue making shareholders happy.

Read More on International Business Times




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Commodities

Referenced Stocks:



Latest News Video






Most Active by Volume:

Company Last Sale Change Net / %
S $ 7 0.32  4.37%
PFE $ 29.10 0.30  1.02%
BAC $ 13.19 0.08  0.60%
MU $ 13.97 0.22  1.60%
SIRI $ 3.37 0.03  0.88%
GE $ 23.98 0.35  1.44%
QQQ $ 72.76 0.82  1.11%
ELN $ 14.15 0.37  2.69%